New Delhi, India – May 19, 2021 – From April 2021, India restarted e-visa facilities for 156 countries. This e-visa facility is applicable for international tourists from 156 countries, who wish to visit for conferences, medical purposes, or business. The e-visa also extends to medical attendants.
India exported nearly $19 billion worth of pharmaceuticals to more than 200 countries in 2019. India is also the third most popular destination for medical tourism, constituting more than 18 percent of the global medical tourism market and expected to grow to $9 billion and 20% of the market share by 2020. But the Covid-19 pandemic has frozen the whole medical tourism market.
“We almost have no revenue until now in 2021. But our expenses are still there” Pradeep CEO of a renowned medical tourism in New Delhi said. “Hope you’re all well & God bless you all in good health. Just to let you know that my grandpa has passed away for the shortage of Pirfenex in treatment during Covid 19. (a medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis). Thank you for your goodness during the past 3 years.” a Romania patient’s grandson text to BonHoa.
“India medical tourism save my life in the past few years. Nintedanib cost in India is only 1/10 of my country. I go to India every half years before Covid 19. But now, all my family exhausted for the expense of my medicine in my country,” a Philippines patient who gets regular treatment said.
On 17th May, the Indian daily count of coronavirus is 267,533, but the related deaths touched a new high, with 4,329 deaths being reported from across the country. There is still a long way to go for India and also for the poor patients all over the world.